Title : Current Treatment of Chronic Lymphocytic Leukemia.

Pub. Date : 2017 Jan

PMID : 28185174






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ibrutinib was proven as a primary choice for patients with the TP53 gene deletion/mutation, who otherwise have no active treatment available. ibrutinib tumor protein p53 Homo sapiens